Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy : Single-Institution Experience in 600 Patients

From conventionally fractionated radiati

From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer

✍ Branislav Jeremić; Biljana Miličić 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

## Abstract ## BACKGROUND The authors' single‐institution experience in patients with early‐stage (I and II) nonsmall cell lung cancer (NSCLC) who were treated between 1980 and 1998 with either conventionally fractionated (CF) radiation therapy (RT), or hyperfractionated (HFX) RT, or HFX RT with c